Outcome of lung cancer according to primary treatment - a health care research study using data cancer registry data (registration according to § 65c SGB V)

Outcome of lung cancer according to primary treatment - a health care research study using data cancer registry data (registration according to § 65c SGB V) - VONKO-009

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00028698

Enrollment

60000

Registered

2022-03-30

Start date

2022-04-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C34

Interventions

Group 1: Observational study: population-based data, cancer registration according to § 65c SGB V, diagnosis: ICD-10 C34, years of diagnosis: 2016-2021

Eligibility

Sex/Gender

All

Age

18 Years to 120 Years

Inclusion criteria

Inclusion criteria: ICD-10 C34; Place of residence in federal state of respective cancer registry

Exclusion criteria

Exclusion criteria: DCO case

Design outcomes

Primary

Measure	Time frame
Population-based description of the outcome of lung cancer according to primary treatment in Germany. We will use data of the clinical cancer registration according to § 65c SGB V (mandatory notification of diagnosis, treatment and follow up of cancer patients). Primary endpoint: observed 5-year-overall survival	—

Secondary

Measure	Time frame
1.) progression-free survival 2.) in the subcohort of individuals with oligometastatic disease: overall survival and progression-free survival	—

Countries

Germany

Contacts

Public ContactAnnika Waldmann

Universität zu Lübeck, Institut für Sozialmedizin und Epidemiologie

Annika.Waldmann@uksh.de0451050051240

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026